Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
CADENCE PHARMACEUTICALS INC
| Metric | CADENCE PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 37 / 100 |
| Revenue (latest) | $24M |
| Net income (latest) | −$1M |
| Operating margin | −116.7% |
| Net margin | −5.8% |
| Return on equity | −3.9% |
| Return on assets | −1.5% |
| Return on capital (ROCE) | −50.8% |
| Debt / equity | 1.60× |
| Revenue growth (YoY) | 195.0% |
| Altman Z″ (distress) | -15.34 |
| Accruals / assets | 24.0% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.